1. Home
  2. RENEU vs TURN Comparison

RENEU vs TURN Comparison

Compare RENEU & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RENEU
  • TURN
  • Stock Information
  • Founded
  • RENEU N/A
  • TURN 1981
  • Country
  • RENEU
  • TURN United States
  • Employees
  • RENEU 2
  • TURN N/A
  • Industry
  • RENEU
  • TURN Finance/Investors Services
  • Sector
  • RENEU
  • TURN Finance
  • Exchange
  • RENEU NYSE
  • TURN Nasdaq
  • Market Cap
  • RENEU N/A
  • TURN 35.3M
  • IPO Year
  • RENEU N/A
  • TURN N/A
  • Fundamental
  • Price
  • RENEU $11.69
  • TURN $4.00
  • Analyst Decision
  • RENEU
  • TURN
  • Analyst Count
  • RENEU 0
  • TURN 0
  • Target Price
  • RENEU N/A
  • TURN N/A
  • AVG Volume (30 Days)
  • RENEU N/A
  • TURN 41.9K
  • Earning Date
  • RENEU N/A
  • TURN 05-12-2025
  • Dividend Yield
  • RENEU N/A
  • TURN N/A
  • EPS Growth
  • RENEU N/A
  • TURN N/A
  • EPS
  • RENEU N/A
  • TURN N/A
  • Revenue
  • RENEU N/A
  • TURN $194,813.00
  • Revenue This Year
  • RENEU N/A
  • TURN N/A
  • Revenue Next Year
  • RENEU N/A
  • TURN N/A
  • P/E Ratio
  • RENEU N/A
  • TURN N/A
  • Revenue Growth
  • RENEU N/A
  • TURN 254.25
  • 52 Week Low
  • RENEU N/A
  • TURN $3.12
  • 52 Week High
  • RENEU N/A
  • TURN $4.20
  • Technical
  • Relative Strength Index (RSI)
  • RENEU 53.53
  • TURN 60.85
  • Support Level
  • RENEU N/A
  • TURN $3.59
  • Resistance Level
  • RENEU $12.00
  • TURN $4.04
  • Average True Range (ATR)
  • RENEU 0.00
  • TURN 0.31
  • MACD
  • RENEU -0.00
  • TURN 0.04
  • Stochastic Oscillator
  • RENEU 0.00
  • TURN 91.78

About RENEU CARTESIAN GROWTH CORPORATION II UNIT COM 1 CL A & 1/3 WT EXP(12/07/2028)

Cartesian Growth Corp II is a blank check company.

About TURN 180 Degree Capital Corp.

180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.

Share on Social Networks: